ImpriMed

ImpriMed is a biotechnology company that uses artificial intelligence to help healthcare providers predict drug responses for cancer patients

ImpriMed uses artificial intelligence to predict the effectiveness of anticancer drugs for dogs with lymphoma or leukemia. By analyzing live cancer cells, they provide personalized treatment options, helping veterinarians choose the most effective chemotherapy for each dog.